Neutralizing Anti-SARS-CoV-2 Antibody Titer and Reported Adverse Effects, in a Sample of Italian Nursing Home Personnel after Two Doses of the BNT162b2 Vaccine Administered Four Weeks Apart.
Alberto ModeneseStefania PaduanoAnnalisa BargelliniRossana BellucciSimona MarchettiFulvio BrunoPietro GrazioliRoberto VivoliFabrizio Maria GobbaPublished in: Vaccines (2021)
The two doses of the BNT162b2 vaccine, even if administered four weeks apart, induced high titers of anti-SARS-CoV-2 neutralizing IgG in all the operators included in the study.